Author:
Massahud Bruna Corrêa,Henriques João César Guimarães,Jacobs Reinhilde,Rosa Rafaela Rangel,Matai Caio Vinícius Bardi
Funder
Research Support Foundation of the State of Minas Gerais - FAPEMIG
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Dentistry (miscellaneous)
Reference25 articles.
1. Hansen D, Brandi L, Rasmussen K. Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomized clinical trial comparing paricalcitol and alfacalcidol. BMC Nephrol. 2009;10:28.
2. Moe SM, Drueke TB, Block GA, Cannata-Andía JB, Elder GJ, Fukagawa M, et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD). Kidney Int Suppl. 2009;113:S1–130.
3. Koizumi M, Komaba H, Nakanishi S, Fujimori A, Fukagawa M. Cincalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 2009;27:790–5.
4. Noleto JW, Ramos IA, Rocha JF, Garcia IR Jr, Salvador Roberto BM. A rare case of regression of brown tumors of tertiary hyperparathyroidism after parathyroidectomy and renal transplant: a 5-year follow-up. Ann Maxillofac Surg. 2016;6:125–9.
5. Lacativa PG, Franco FM, Pimentel JR, Patrício Filho PJ, Gonçalves MD, Farias ML. Prevalence of radiological findings among cases of severe secondary hyperparathyroidism. São Paulo Med J. 2009;127:71–7.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献